SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha and beta proteins (a+b) (23004)
(-)
Fold: MHC antigen-recognition domain (585)
(-)
Superfamily: MHC antigen-recognition domain (585)
(-)
Family: MHC antigen-recognition domain (533)
(-)
Protein domain: Class I MHC, alpha-1 and alpha-2 domains (294)
(-)
Human (Homo sapiens), HLA-A2.1 [TaxId: 9606] (92)
1AKJA:1-181COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8
1AO7A:1-181COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201
1B0GA:1-181; D:1-181CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2-MICROGLOBULIN/PEPTIDE P1049 COMPLEX
1B0RA:1-181CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP
1BD2A:1-181COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
1DUYA:1-181; D:1-181CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX
1DUZA:1-181; D:1-181HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN
1EEYA:1-181; D:1-181CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)
1EEZA:1-181; D:1-181CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)
1HHGA:1-181; D:1-181THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHHA:1-181THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHIA:1-181; D:1-181THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHJA:1-181; D:1-181THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1HHKA:1-181; D:1-181THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1I1FA:1-181; D:1-181CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
1I1YA:1-181; D:1-181CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
1I4FA:1-181CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX
1I7RA:1-181; D:1-181CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
1I7TA:1-181; D:1-181CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
1I7UA:1-181; D:1-181CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V
1IM3A:1-181; E:1-181; I:1-181; M:1-181CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
1JF1A:1-181CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A
1JHTA:1-181CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A.
1LP9A:1-181; H:1-181XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
1OGAA:1-181A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
1P7QA:1-181CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR
1QEWA:1-181HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)
1QR1A:1-181; D:1-181POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1QRNA:1-181CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
1QSEA:1-181STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
1QSFA:1-181STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1S8DA:1-181STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A
1S9WA:1-181CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2
1S9XA:1-181CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQA, IN COMPLEX WITH HLA-A2
1S9YA:1-181CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2
1T1WA:1-181STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V
1T1XA:1-181STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L
1T1YA:1-181STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V
1T1ZA:1-181STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A
1T20A:1-181STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I
1T21A:1-181STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL
1T22A:1-181STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL
1TVBA:1-181; D:1-181CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2
1TVHA:1-181; D:1-181CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2
2AV1A:1-181; D:1-181CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.
2AV7A:1-181; D:1-181CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.
2BCKA:1-181; D:1-181CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE
2BNQA:1-181STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2BNRA:1-181STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2C7UA:1-181; D:1-181CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.
2CLRA:1-181; D:1-181THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE
2F53A:1-181DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
2F54A:1-181; F:1-181DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2GITA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2GJ6A:1-181THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
2GT9A:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART-1(26-35) PEPTIDE
2GTWA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE HAVING A27L SUBSTITUTION
2GTZA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE HAVING A28L SUBSTITUTION
2GUOA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN-A/MART-1(27-35) PEPTIDE
2J8UA:1-181; H:1-181LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
2JCCA:1-181; H:1-181AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2P5EA:1-181CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2P5WA:1-181CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2PYEA:1-181CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
2UWEA:1-181; H:1-181LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
2V2WA:1-181; D:1-181T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
2V2XA:1-181; D:1-181T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.
2VLJA:1-181THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLKA:1-181THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLLA:1-181; D:1-181THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VLRA:1-181; F:1-181THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
3BGMA:1-181CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BH8A:1-181CRYSTAL STRUCTURE OF RQA_M PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BH9A:1-181CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3BHBA:1-181CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
3HLAA:1-181HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1
3O3AA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
3O3BA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
3O3DA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2
3O3EA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1
3O4LA:1-181GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3PWJA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT
3PWLA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE
3PWNA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
3PWPA:1-181THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3QDGA:1-181THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJA:1-181THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMA:1-181THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEQA:1-181THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QFDA:1-181; D:1-181HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE
3QFJA:1-181THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
4L3CA:1-181; C:1-181; E:1-181; G:1-181; I:1-181; K:1-181; M:1-181; O:1-181; Q:1-181; S:1-181; U:1-181; W:1-181; Y:1-181STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT